Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1043]

Androgen receptor signalling contributes to targeted therapy resistance in melanoma

Androgen receptor signalling contributes to targeted therapy resistance in melanoma

A crystal ball in the fight against oesophageal cancer

A crystal ball in the fight against oesophageal cancer

NICE recommends abemaciclib in combination with endocrine therapy for adjuvant treatment of HR+/HER2- early breast cancer

NICE recommends abemaciclib in combination with endocrine therapy for adjuvant treatment of HR+/HER2- early breast...

Mechanical transmission enables EMT cancer cells to drive epithelial cancer cell migration to guide tumour spheroid disaggregation

Mechanical transmission enables EMT cancer cells to drive epithelial cancer cell migration to guide tumour...

Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer

Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer

Researchers discover genes that predict good response to blood cancer therapy

Researchers discover genes that predict good response to blood cancer therapy

Androgen receptor signaling contributes to targeted therapy resistance in melanoma

Androgen receptor signaling contributes to targeted therapy resistance in melanoma

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast cancer with low HER2 expression levels

ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast cancer with low...

More from ecancer